Tag Archives: repaglinide

Novo nordisk – repaglinide combination patent invalid

Yesterday, The district court of Michigan ruled that OB listed 6,677,358 (exp: Jun 12, 2018) patent is invalid and unenforceable. Press release “… The district court ruled that the patent, which covers the combination use of repaglinide and metformin for the treatment of type 2 … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , , | Leave a comment